buoyantintelligence
  • 01Overview
  • 02Portfolio
  • 03Company Atlas
    • Buoyant book
    • All listed companies
  • 04Screener & valuation
  • 05House view
  • 06Markets
  • 07India top-down
  • 08Investors
  • 09Library & data
Release
August 2026 · rev 1
Opportunities PMS · Published
As at 31 Aug 2026 · IST₹ · ₹ cr · BSE 500 TRI
Present
Internal working platform. Published figures are extracted from the August 2026 source package and reviewed; reference prices and fundamentals are unlicensed working data, not for redistribution. Past performance is not indicative of future returns.
All listed companies/Anthem Biosciences Limited
03 /Listed universe · Healthcare · CDMO

Anthem Biosciences Limited.

Value itCompareScreener.in ↗Tijori ↗NSE ↗BSE ↗
Snapshot

Healthcare · CDMO

Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients. The company offers contract research development and manufacturing services, such as end-to-end services across the new chemical entity and new biological entity lifecycles, as well as engages in contract research, development, and manufacturing of development batches of molecules used for clinical trials up to commercial manufacturing for small molecules and biologics. It also manufactures and sells specialized fermentation-based active pharmaceutical ingredients, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. The company was incorporated in 2006 and is based in Bengaluru, India.

Market cap
₹50,252 cr
P/E (TTM)
87.9
P/B (latest)
16.5
ROE (TTM)
19.5%
ROCE (TTM)
27.8%
Sales CAGR 3y
26.2%
PAT CAGR 3y
15.4%
Debt / equity
0.02x
Promoter
71.4%
Dividend yield
0.22%
Size
Mid
Codes
ANTHEM · 544449
Price

₹868.35 · 29 Sept 2026

1M
−3.5%
3M
+12.0%
6M
+27.4%
YTD
+36.1%
1Y
+13.4%
3Y
—
5Y
—
vs 52w high
−9.3%

52-week ₹592.4 – ₹957.8 · ADTV ₹73.3 cr · price-only.

Trend

Sales and net profit by fiscal year, ₹ crore

Not in the Buoyant book: no house thesis or target is carried. Exchange masters, Tijori and the reference price feed as stated on each tab. All listed companies · NSE EQ